Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach
Open Access
- 22 February 2005
- Vol. 103 (7) , 1439-1446
- https://doi.org/10.1002/cncr.20966
Abstract
BACKGROUND Although the incidence of adenocarcinoma of the stomach has decreased over the past several decades, gastric cardia carcinoma has increased over the same period. METHODS The clinicopathologic characteristics and immunohistochemical staining results of 21 proteins were investigated in 165 patients with cardia carcinoma, including 74 patients with true cardia carcinoma and 91 patients with subcardia carcinoma, and the results were compared with the results from 564 patients with noncardia carcinoma. RESULTS In the clinicopathologic analysis, patients who had cardia carcinoma tended to have tumors with poorly differentiated histology according to the World Health Organization classification system (P = 0.012), diffuse type according to the Lauren classification system (P = 0.049), and advanced pathologic TNM stage (P < 0.001). On immunohistochemical staining, loss of the p16 (P = 0.038) and smad4 (P < 0.001) tumor suppressor genes was more frequent in cardia carcinoma than in noncardia carcinoma. Carcinoembryonic antigen and CD44 overexpression were more frequent in patients with cardia carcinoma (P < 0.05). Conversely, patients who had cardia carcinoma exhibited less frequent expression of MUC1 (P = 0.008) and MUC5AC (P = 0.006) compared with patients who had noncardia carcinoma. Epstein–Barr virus infection was more common in patients with cardia carcinoma (P < 0.001). In the survival analysis, the patients with cardia carcinoma had a poorer prognosis. In the multivariate analysis, tumor location in the cardia was confirmed as an independent, poor prognostic factor in patients with gastric carcinoma. CONCLUSION Cardia carcinoma and noncardia carcinoma differed in their clinicopathologic characteristics and in their alterations of gene expression, as evaluated by immunohistochemistry. The current results support the hypothesis that cardia carcinoma forms a specific category of gastric carcinoma that is distinct from noncardia carcinoma. Cancer 2005. © 2005 American Cancer Society.Keywords
This publication has 29 references indexed in Scilit:
- Epstein-Barr Virus-Positive Gastric Carcinoma Has a Distinct Protein Expression Profile in Comparison with Epstein-Barr Virus-Negative CarcinomaClinical Cancer Research, 2004
- Are carcinomas of the cardia oesophageal or gastric adenocarcinomas?European Journal Of Cancer, 2003
- Tumour suppressor gene expression correlates with gastric cancer prognosisThe Journal of Pathology, 2003
- Epstein–Barr virus and gastric carcinoma in Western patients: comparison of pathological parameters and p53 expression in EBV‐positive and negative tumoursHistopathology, 2000
- Changes in the site- and histology-specific incidence of gastric cancer during a 50-year periodGastroenterology, 1995
- Estimates of the worldwide incidence of eighteen major cancers in 1985International Journal of Cancer, 1993
- Improving survival in gastric cancer: Review of 5-year survival rates in English language publications from 1970British Journal of Surgery, 1992
- The rising trend in oesophageal adenocarcinoma and gastric cardiaEuropean Journal Of Cancer Prevention, 1992
- A genetic model for colorectal tumorigenesisCell, 1990